Cystic Hepatic Neuroendocrine Tumor: A Rare Entity.

Clin Nucl Med

From the Departments of Diagnostic, Interventional, and Pediatric Radiology.

Published: December 2021

A 70-year-old man presented with unspecific abdominal symptoms and weight loss was referred for a sonographic examination. Sonography revealed 3 cystic hepatic masses in an otherwise unremarkable liver. Contrast-enhanced MRI of the liver was performed to characterize the hepatic lesions and elucidate their etiology. The differential diagnosis was primarily parasitic disease or metastases with cystic transformations. 68Ga-DOTATOC PET/CT revealed the neuroendocrine origin of these lesions, confirmed by biopsy. However, the primary site of the neuroendocrine tumor remained unclear, leaving primary hepatic neuroendocrine tumor and neuroendocrine cancer of unknown primary as possible diagnostic options.

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000003803DOI Listing

Publication Analysis

Top Keywords

neuroendocrine tumor
12
cystic hepatic
8
hepatic neuroendocrine
8
neuroendocrine
5
tumor rare
4
rare entity
4
entity 70-year-old
4
70-year-old man
4
man presented
4
presented unspecific
4

Similar Publications

There are numerous versions of octreotide and octreotate, including DOTAMTATE, DOTATATE, JR11, and lead-specific chelator (PSC)-PEG2-TOC. These peptides, which can be either analogs or antagonists, are used in nuclear medicine for diagnostic imaging or targeted radionuclide therapy of neuroendocrine tumors that are positive for somatostatin receptors (SSTRs). Despite their structural and targeting similarities, they have distinct properties and clinical uses.

View Article and Find Full Text PDF

Spinal extramedullary tumors are the most common types of schwannomas and meningiomas. Therefore, most spinal cord surgeons should safely perform surgeries for these tumors. The posterior approach with conventional laminectomy is sufficient for the safe resection of almost all spinal extramedullary tumors.

View Article and Find Full Text PDF

Cervical sympathetic paraganglioma: A rare case managed with embolization and surgery with successful nerve recovery.

Int J Surg Case Rep

January 2025

University Hospital Center "Sestre Milosrdnice", Department for Diagnostic and Interventional Radiology, Vinogradska cesta 29, 10000 Zagreb, Croatia; University Hospital Center "Sestre Milosrdnice", Department of Otorhinolaryngology and Head and Neck Surgery, Vinogradska cesta 29, 10000 Zagreb, Croatia.

Introduction And Importance: Sympathetic paragangliomas are rare neuroendocrine tumors arising from the sympathetic nervous system.

Case Presentation: We present a case of a 48-year-old woman with an extremely rare paraganglioma arising from the cervical sympathetic chain that was presented to the emergency department with symptoms of respiratory insufficiency and dysphagia. Imaging revealed a highly vascularized tumor originating from the jugular fossa.

View Article and Find Full Text PDF

Prognostic value of immune biomarkers in melanoma loco-regional metastases.

PLoS One

January 2025

Department of Clinical Medicine, Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.

The prognosis for patients with melanoma loco-regional metastases is very heterogenous. Adjuvant PD-L1-inhibitors have improved clinical outcome for this patient group, but the prognostic impact of tumour PD-L1 expression and number of tumour infiltrating lymphocytes (TILs) is still largely unknown. Here, we investigated the impact on survival for CD3, CD8, FOXP3 and PD-L1 TIL counts and tumour PD-L1 expression in melanoma loco-regional metastases.

View Article and Find Full Text PDF

One-day dual-tracer examination in neuroendocrine neoplasms: a real advantage of low activity LAFOV PET imaging.

Eur J Nucl Med Mol Imaging

January 2025

Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Otfried-Mueller-Str. 14, 72076, Tuebingen, Germany.

Purpose: Somatostatin receptor (SSTR)-PET is crucial for effective treatment stratification of neuroendocrine neoplasms (NENs). In highly proliferating or poorly differentiated NENs, dual-tracer approaches using additional [F]FDG PET can effectively identify SSTR-negative disease, usually requiring separate imaging sessions. We evaluated the feasibility of a one-day dual-tracer imaging protocol with a low activity [F]FDG PET followed by an SSTR-PET using the recently introduced [F]SiFAlin-TATE tracer in a long axial field-of-view (LAFOV) PET/CT scanner and its implications in patient management.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!